Related Experiment Video
Updated: Aug 13, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Risk of patent foramen ovale for thromboembolic events in all age groups
M A de Belder1, L Tourikis, G Leech
1Department of Cardiological Sciences, St. George's Hospital Medical School, Tooting, London, United Kingdom.
Insights
A patent foramen ovale (PFO) is linked to thromboembolic events, especially in patients without other risk factors. Echocardiography revealed PFO in 26% of patients with events and no risk factors, versus 3.2% in controls.
Area of Science:
- Cardiology
- Neurology
- Vascular Medicine
Background:
- A patent foramen ovale (PFO) is a potential risk factor for thromboembolic events.
- Previous studies suggest a PFO may be present in 20-35% of the general population.
Purpose of the Study:
- To investigate the association between PFO and thromboembolic events in patients.
- To compare PFO prevalence in patients with and without recognized risk factors for thromboembolism.
Main Methods:
- 104 patients with stroke, TIA, or peripheral artery embolus underwent contrast echocardiography.
- 94 control patients without thromboembolic events also underwent echocardiography.
- Precordial and transesophageal contrast echocardiography were used for PFO detection.
Main Results:
- A PFO was detected in 22 patients (21% of group I).
- PFO prevalence was 26% in patients with events and no risk factors (group Ia), 14% in patients with events and risk factors (group Ib), and 3.2% in controls (group II).
- The odds of PFO were significantly higher in group Ia versus group II (10:1) and group Ib versus group II (5:1).
Conclusions:
- PFO is significantly associated with thromboembolic events, particularly in patients without other identifiable risk factors.
- The study highlights the importance of considering PFO in the etiological workup of thromboembolic events.
- Lower-than-expected PFO prevalence may be due to patient selection or limitations in echocardiographic detection.
Abstract:
The association between a patent foramen ovale (PFO) and thromboembolic events in young patients has been reported. Autopsy data suggest that a PFO may be present in 20 to 35% of the population. To further assess the role of a PFO in patients with possible thromboembolic events, precordial and transesophageal contrast echocardiography was performed in 104 consecutive patients (age range 16 to 84 years) presenting with a stroke, transient ischemic attack or peripheral artery embolus (group I). These patients were compared with 94 consecutive patients (age range 23 to 82 years) undergoing transesophageal echocardiography for other reasons (group II). A PFO was found in 22 patients; 9 of 35 (26%) with an event but no risk factor (group Ia), 10 of 69 (14%) with an event but a recognized risk factor (group Ib), and 3 of 94 control patients (3.2%) (group II) (group Ia vs II: relative odds 10:1, p less than 0.001; group Ib vs II: relative odds 5:1, p less than 0.01; and group Ia vs Ib: p = not significant). The detection of a PFO was not related to age. The relatively low prevalence of a PFO in this study may reflect patient selection, but other explanations include: (1) Transesophageal contrast echocardiography may be relatively insensitive for its detection; (2) the prevalence in the general population may have been overestimated; and (3) most PFOs are very small, clinically insignificant and undetectable with this technique.(ABSTRACT TRUNCATED AT 250 WORDS)
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Pulmonary Embolism I: Introduction

